Vagus nerve stimulation for depression: Rationale, anatomical and physiological basis of efficacy and future prospects

Acta Neurochirurgica, Supplementum

Volumn , Issue 97 PART 2, 2007, Pages 407-416

  Park, M C ^a   Goldman, M A ^a   Carpenter, L L ^b   Price, L H ^b   Friehs, Gerhard M ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b BUTLER HOSPITAL   (United States)

Author keywords

major depressive disorder; treatment resistant depression; Vagus nerve stimulation

Indexed keywords

DEPRESSION; ELECTROCONVULSIVE THERAPY; ELECTROSTIMULATION THERAPY; HISTOLOGY; HUMAN; METHODOLOGY; REVIEW; VAGUS NERVE;

DEPRESSION; ELECTRIC STIMULATION THERAPY; ELECTROCONVULSIVE THERAPY; HUMANS; VAGUS NERVE;

EID: 85052609924     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-33081-4_46     Document Type: Review

References (100)

1. Amar AP, Heck CN, Levy ML, Smith T, De Giorgio CM, Oviedo S, Apuzzo ML (1998) An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique and outcome. Neurosurgery 43:1265-1276
2. American Psychiatric Association (2000) Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 157 Suppl 4:1-45
3. nd edn. American Psychiatric Press, Washington, DC
4. Bailey P, Bremer F (1938) A sensory cortical representation of the vagus nerve: with a note on the effects of low blood pressure on the cortical electrogram. J Neurophysiol 1:405-412
5. Ballenger JC, Post RM (1980) Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 137:782-790
6. Barraclough B, Bunch J, Nelson B, Sainsbury P (1974) A hundred cases of suicide: clinical aspects. Br J Psychiatry 125:355-373
7. Ben-Menachem E, Manon-Espaillat R, Ristanovic R, Wilder BJ, Stefan H, Mirza W, Tarver WB, Wernicke JF (1994) Vagus nerve stimulation for treatment of partial seizures: I. a controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia 35:616-626
8. Ben-Menachem E, Hamberger A, Hedner T, Hammond EJ, Uthman BM, Slater J, Treig T, Stefan H, Ramsay RE, Wernicke JF, Wilder BJ (1995) Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res 20:221-227
9. Bodenlos JS, Kose S, Borckardt JJ, Nahas Z, Shaw D, O'Neil PM, George MS (2006) Vagus nerve stimulation acutely alters food craving in adults with depression. Appetite Epub 2006 Oct. 30
10. Bohning DE, Lomarev MP, Denslow S, Nahas Z, Shastri A, George MS (2001) Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI. Invest Radiol 36:470-479
11. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG et al (1994) Efficacy of divalproex versus lithium and placebo in the treatment of mania. JAMA 271:918-924
12. Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS (1997) Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 54:364-374 (Pubitemid 27171922)
13. Bruce DA (1998) Implantation of a vagus nerve stimulator for refractory partial seizures: surgical outcomes of 454 study patients. Epilepsia 39 Suppl 6:92-93
14. Burke MJ, Husain MM (2006) Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression. J ECT 22:218-222
15. Calabrese JR, Bowden CL, McElroy SL, Cookson J, Andersen J, Keck PE Jr, Rhodes L, Bolden-Watson C, Zhou J, Ascher JA (1999) Spectrum of activity in lamotrigine in treatment-refractory bipolar disorder. Am J Psychiatry 156:1019-1023
16. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (1999) A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60:79-88
17. Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH (2004) Effects of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biol Psychiatry 56:418-426
18. Chae JH, Nahas Z, Lomarev M, Denslow S, Lorberbaum JP, Bohning DE, George MS (2003) A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res 37:443-455
19. Conway CR, Sheline YI, Chibnall JT, George MS, Fletcher JW, Mintun MA (2006) Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Research: Neuroimaging 146:179-184
20. Cullen M, Mitchell P, Brodaty H, Boyce P, Parker G, Hickie I, Wilhelm K (1991) Carbamazepine for treatment-resistant melancholia. J Clin Psychiatry 52:472-476
21. Dell P, Olson R (1951) Projections 'secondaries' mesencephaliques, diencephaliques et amygdaliennes des afferences viscerales vagales. C R Seances Soc Biol Fil 145:1088-1091
22. Depression Guideline Panel (1993) Depression in Primary Care: Volume 1. Detection and Diagnosis (Clinical Guideline No. 5, AHCPR Publication No. 93-0550). Rockville, MD: U. S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Washington, DC
23. th World Congress of Biological Psychiatry. Berlin, Germany
24. Dorpat TL, Ripley HS (1960) A study of suicide inthe Seattle area. Compr Psychiatry 1:349-359
25. Dorr AE, Debonnel G (2006) Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther 318:890-898
26. Ebert D, Feistel H, Barocka A, Kaschka W (1994) Increased limbic flow and total sleep deprivation in major depression with melancholia. Psychiatry Res 55:101-109
27. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE (2000) Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 42:203-210
28. Fawcett J (1993) The morbidity and mortality of clinical depression. Int Clin Psychopharmacol 8:217-220
29. Fisher RS, Handforth A (1999) Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 53:666-669
30. Foley JO, Dubois F (1937) Quantitative studies of the vagus nerve in the cat. I: the ratio of sensory and motor studies. J Comp Neurol 67:49-67
31. Folkerts HW, Michael N, Tolle R, Schonauer K, Mucke S, Schulze-Monking H (1997) Electroconvulsive therapy vs. paroxetine in treatment-resistant depression - a randomized study. Acta Psychiatr Scand 96:334-342
32. Gangadhar B, Kapur R, Kalyanasundaram S (1982) Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double blind study. Br J Psychiatry 141:367-371
33. Garnett ES, Nahmias C, Scheffel A, Firnau G, Upton AR (1992) Regional cerebral blood flow in man manipulated by direct vagal stimulation. Pacing Clin Electrophysiol 15:1579-1580
34. George MS, Sackeim HA, Rush AJ, Marangell LB, Nahas Z, Husain MM, Lisanby S, Burt T, Goldman J, Ballenger JC (2000) Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry 47:287-295 (Pubitemid 30109241)
35. George MS, Rush AJ, Sackeim HA, Marangell LB (2003) Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders. Int J Neuropsychopharmacol 6:73-83
36. George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, Dunner D, Schwartz T, Carpenter L, Burke M, Ninan P, Goodnick P (2005) A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 58:364-373
37. Ghaemi SN, Katzow JJ, Desai SP, Goodwin FK (1998) Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry 59:426-429
38. Goodwin FK, Jamison KR (1990) Manic-depressive illness. Oxford University Press, New York
39. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER (1993) The economic burden of depression in 1990. J Clin Psychiatry 54:405-418
40. Handforth A, De Giorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, Henry TR, Collins SD, Vaughn BV, Gilmartin RC, Labar DR, Morris GL 3rd, Salinsky MC, Osorio I, Ristanovic RK, Labiner DM, Jones JC, Murphy JV, Ney GC, Wheless JW (1998) Vagus nerve stimulation for treatment of partial-onset seizures: a randomized active-control trial. Neurology 51:48-55
41. Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper J, Labar DR (2000) A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 1:93-99
42. Hatton KW, McLarney JT, Pittman T, Fahy BG (2006) Vagal nerve stimulation: overview and implications for anesthesiologists. Anesth Analg 103:1241-1249
43. Henry TR (2000) Functional imaging studies of epilepsy therapies. Adv Neurol 83:305-317
44. Henry TR, Bakay RA, Votaw JR, Pennell PB, Epstein CM, Faber TL, Grafton ST, Hoffman JM (1998) Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia 39:983-990
45. Henry TR, Votaw JR, Bakay RA, Pennell PB, Epstein CM, Faber TL, Grafton ST, Hoffman JM (1998) Vagus nerve stimulation - induced cerebral blood flow changes differ in acute and chronic therapy of complex partial seizure. Epilepsia 39 Suppl 6:92
46. Henry TR, Votaw JR, Pennell PB, Epstein CM, Bakay RA, Faber TL, Grafton ST, Hoffman JM (1999) Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology 52:1166-1173
47. Hirschfeld RM, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, Endicott J, Froom J, Goldstein M, Gorman JM, Marek RG, Maurer TA, Meyer R, Philips K, Ross J, Schwenk TL, Sharfstein SS, Thase ME, Wyatt RJ (1997) The national depressive and manic-depressive association consensus statement on the undertreatment of depression. JAMA 277:333-340 (Pubitemid 27045015)
48. Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher P (1985) Efficacy of ECT; a meta-analysis. Am J Psychiatry 142:297-302
49. Ketter TA, George MS, Kimbrell TA, Benson BA, Post RM (1997) Functional brain imaging in mood and anxiety disorders. Curr Rev Mood Anxiety Disord 1:96-112
50. Knoll J, Stegman K, Suppes T (1998) Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord 49:229-233
51. 15O blood flow imaging. Neurosurgery 39:426-430
52. Krahl SE, Clark KB, Smith DC, Browning RA (1998) Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39:709-714
53. Lomarev M, Denslow S, Nahas Z, Chae JH, George MS, Bohning DE (2002) Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. J Psychiatr Res 36:219-227
54. MacLean PD (1990) Triune brain in evolution: role in paleocerebral functions. Plenum Press, New York
55. Marangell LB, Rush AJ, George MS, Sackeim HA, Johnson CR, Husain MM, Nahas Z, Lisanby SH (2002) Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 51:280-287
56. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT (1997) Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8:1057-1061
57. McElroy SI, Soutullo CA, Keck PE Jr, Kmetz GF (1997) A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry 9:99-103
58. Medical Research Council (1965) Clinical trial of the treatment of depressive illness. Report to the Medical Research Council by its Clinical Psychiatry Committee. Br Med J 1:881-886
59. Merrill CA, Jonsson MA, Minthon L, Ejnell H, C-son Silander H, Blennow K, Karlsson M, Nordlund A, Rolstad S, Warkentin S, Ben-Menachem E, Sjogren MJ (2006) Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year. J Clin Psychiatry 67:1171-1178
60. Morris GL 3rd, Mueller WM (1999) Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology 53:1731-1735
61. Murray CJL, Lopez AD (1996) The global burden of disease in 1990: final results and their sensitivity to alternative epidemiological perspectives, discount rates, age-weights and disability weights. In: Murray CJL, Lopez AD (eds) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard University Press, Cambridge, pp 247-293
62. Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, Martinez JM, George MS (2005) Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66:1097-1104
63. Naritoku DK, Terry WJ, Helfert RH (1995) Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res 22:53-62
64. Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, George MS, Charney DS, Brannan SK (2006) VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 31:1345-1355
65. Oquendo MA, Malone KM, Ellis SP, Sackeim HA, Mann JJ (1999) Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. Am J Psychiatry 156:190-194
66. Ottersen OP (1981) Afferent connections to the amygdaloin complex of the rat with some observations in the cat. III. Afferents from the lower brain stem. J Comp Neurol 202:335-356
67. Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, Rummans TA, O'Connor KM, Rasmussen KG Jr, Bernstein HJ, Biggs M, Bailine SH, Kellner CH (2001) ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 17:244-253
68. Post RM, Ketter TA, Denicoff K, Pazzaglia PJ, Leverich GS, Marangell LB, Callahan AM, George MS, Frye MA (1996) The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berl) 128:115-129
69. th century. Neuropsychobiology 38:152-166
70. Ricardo JA, Koh ET (1978) Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res 153:1-26
71. Ring HA, White S, Costa DC, Pottinger R, Dick JP, Koeze T, Sutcliffe J (2000) A SPECT study of the effect of vagal nerve stimulation on thalamic activity in patients with epilepsy. Seizure 9:380-384
72. Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C, Nahas Z, Haines S, Simpson RK Jr, Goodman R (2000) Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 47:276-286
73. Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, Rapaport MH, Zajecka J, Nierenberg AA, Husain MM, Ginsberg D, Cooke RG (2005) Vagus nerve stimulation for treatmentresistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 58:347-354
74. Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno F, Schwartz T, Conway C, Burke M, Barry JJ (2005) Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 58:355-363 (Pubitemid 41219703)
75. Sackeim HA (1999) The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J ECT 15:5-26
76. Sackeim HA (2001) The definition and meaning of treatmentresistant depression. J Clin Psychiatry 62 Suppl 16:10-17
77. Sackeim HA, Decina P, Prohovnik I, Malitz S, Resor SR (1983) Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry 18:1301-1310
78. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM (1993) Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328:839-846
79. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57:425-434
80. Sackeim HA, Keilp JG, Rush AJ, George MS, Marangell LB, Dormer JS, Burt T, Lisanby SH, Husain M, Cullum CM, Oliver N, Zboyan H (2001) The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol Behav Neurol 14:53-62
81. Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, Johnson CR, Seidman S, Giller C, Haines S, Simpson RK Jr, Goodman RR (2001) Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacololgy 25:713-728
82. Schachter SC (2002) Vagus nerve stimulation therapy summary: five years after FDA approval. Neurology 59 Suppl 4:S15-S20
83. Schachter SC, Saper CB (1998) Vagus nerve stimulation (progress in epilepsy research). Epilepsia 39:677-686
84. Schaffer CB, Schaffer LC (1997) Gabapentin in the treatment of bipolar disorder. Am J Psychiatry 154:291-292
85. Scherrmann J, Hoppe C, Kral T, Schramm J, Elger CE (2001) Vagus nerve stimulation: clinical experience in a large patient series. J Clin Neurophysiol 18:408-414
86. Souery D, Amsterdam J, de Montigny C, Lecrubier Y, Montgomery S, Lipp O, Racagni G, Zohar J, Mendlewicz J (1999) Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol 9:83-91
87. Tecoma ES, Iragui VJ (2006) Vagus nerve stimulation use and effect in epilepsy: what have we learned? Epilepsy Behav 8:127-136
88. Ter Horst GJ, Streetland C (1994) Ascending projection of the solitary tract nucleus. In: Robin I, Barraco A (eds) Nucleus of the solitary tract. CRC Press, London
89. Thase ME, Rush AJ (1995) Treatment-resistant depression. In: Bloom F, Kupfer D (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1081-1098
90. Van Bockstaele EJ, Peoples J, Valentino RJ (1999) Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biol Psychiatry 6:1352-1363
91. Van der Kooy D, Koda LY, McGinty JF, Gerfen CR, Bloom FE (1984) The organization of projections from the cortex, amygdala, and hypothalamus to the nucleus of the solitary tract in the rat. J Comp Neurol 224:1-24
92. Van Laere K, Vonck K, Boon P, Brans B, Vandekerckhove T, Dierckx R (2000) Vagus nerve stimulation in refractory epilepsy: SPECT activation study. J Nucl Med 41:1145-1154
93. Vonck K, Boon P, Van Laere K, D'Have M, Vandekerckhove T, O'Connor S, Brans B, Dierckx R, De Reuck J (2000) Acute single photon emission computed tomographic study of vagus nerve stimulation in refractory epilepsy. Epilepsia 41:601-609
94. Walker BR, Easton A, Gale K (1999) Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia 40:1051-1057
95. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE Jr (1992) Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 149:538-543
96. Zabara J (1985) Control of hypersynchronous discharge in epilepsy. Electroencephalogr Clin Neurophysiol Suppl 61:S162
97. Zabara J (1985) Time course of seizure control to brief, repetitive stimuli. Epilepsia 26:518
98. Zabara J (1992) Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia 33:1005-1012
99. Zardetto-Smith AM, Gray TS (1990) Organization of the peptidergic and catecholaminergic efferents from the nucleus of the solitary tract to the rat amygdala. Brain Res Bull 25:875-887
100. Zobel A, Joe A, Freymann N, Clusmann H, Schramm J, Reinhardt M, Biersack HJ, Maier W, Broich K (2005) Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach. Psychiatry Res 139:165-179